ACA
AEON.WS

Arena Capital Advisors’s AEON Biopharma Inc AEON.WS Stock Holding History

Arena Capital Advisors’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-29,915
Closed -$1.65K – 68
2023
Q1 		$1.65K Hold
29,915
– – ﹤0.01% 96
2022
Q4 		$1.36K Hold
29,915
– – ﹤0.01% 138
2022
Q3 		$2K Hold
29,915
– – ﹤0.01% 213
2022
Q2 		$4K Hold
29,915
– – ﹤0.01% 254
2022
Q1 		$9K Sell
29,915
-53,285
-64% -$22K ﹤0.01% 285
2021
Q4 		$42K Hold
83,200
– – ﹤0.01% 319
2021
Q3 		$49K Buy
+83,200
New +$60.9K ﹤0.01% 334

Other funds holding AEON.WS

SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

Arena Capital Advisors's AEON.WS Position: Q2 2023 in Review

Arena Capital Advisors sold out of AEON Biopharma Inc (AEON.WS) in Q2 2023, closing a stake of 29,915 shares — an estimated $1.65K sold.

Arena Capital Advisors first reported a position in AEON.WS in Q3 2021 and held it in 7 quarters. The position peaked at $49K in Q3 2021. 42 funds tracked by Wall St. Rank hold AEON.WS as of Q2 2023.

  • Arena Capital Advisors reported no remaining AEON Biopharma Inc position as of Q2 2023 after selling out during the quarter.
  • Arena Capital Advisors sold 29,915 AEON Biopharma Inc shares in Q2 2023, an estimated $1.65K.
  • Arena Capital Advisors first reported a position in AEON Biopharma Inc in Q3 2021 and held it in 7 quarters.
  • Arena Capital Advisors's AEON Biopharma Inc position peaked at $49K in Q3 2021.
  • 42 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q2 2023.

Based on Arena Capital Advisors's 13F filing for Q2 2023, filed 1 Aug 2023.